December 21, 2011 - Titan Pharmaceuticals Adopts Stockholder Rights Plan, Files Shelf Registration of Securities on Form S-3

December 1, 2011 - Titan Pharmaceuticals Confirms Regulatory Guidance for Probuphine

November 15, 2011 - Titan Pharmaceuticals Announces Third Quarter 2011 Financial Results

November 15, 2011 - Titan Pharmaceuticals Enters Into $15 Million Royalty Sale Agreement with Deerfield Management

November 11, 2011 - Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2011 Financial Results

October 26, 2011 - Titan Pharmaceuticals Provides Probuphine Update After Meeting With U.S. Food and Drug Administration

August 31, 2011 - Titan Pharmaceuticals Confirms Meeting With U.S. Food and Drug Administration

August 16, 2011 - Titan Pharmaceuticals Announces Second Quarter 2011 Financial Results

August 16, 2011 - Titan Pharmaceuticals Provides Additional Positive Results in Confirmatory Phase 3 Trial Of Probuphine

August 9, 2011 - Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2011 Financial Results and Probuphine Phase 3 Clinical Study Results

July 11, 2011 - Titan Pharmaceuticals Announces Positive Top Line Results in Confirmatory Phase 3 Trial of Probuphine

June 30, 2011 - Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine

June 27, 2011 - Titan Pharmaceuticals to Present At 2011 Bio International Convention

June 17, 2011 - Titan Pharmaceuticals Provides Additional Details on Confirmatory Phase 3 Study of Probuphine

June 17, 2011 - Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine

May 16, 2011 - Titan Pharmaceuticals Announces First Quarter 2011 Financial Results

March 24, 2011 - Titan Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results

March 16, 2011 - Titan Pharmaceuticals Enters into a $20 Million Credit Facility with Deerfield Management

February 3, 2011 - Titan Reports Fourth Quarter 2010 Fanapt® Royalty